NSN 6505-01-491-2834, 6505014912834
CIPROFLOXACIN TABLETS,USP

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 014912834
Codification Country: United States
Item Name Code: INC 45499
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-491-2834

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-491-2834

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-491-2834

National Stock Number (NSN) 6505-01-491-2834, or NIIN 014912834, (ciprofloxacin tablets,usp) was assigned October 17, 2001 in the Federal Logistics Information System (FLIS). NIIN 014912834 was cancelled on August 2, 2015, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, there are no suppliers listed as an Active supplier for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of May 06, 2014. There have been 3 contracts issued for this part number, with 3 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 2 different suppliers. The last contract numbers awarded were: SPE2DP14V0398, SPM2DP08M1274, SPM2DP07V0242. The total value of the awarded contracts has been US$ 2,142.48.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 45499. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505014912834 does not contain precious metals.

This information was last updated on Aug 01, 2025.

Technical Characteristics

III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) CIPROFLOXACIN TABLETS USP 500MG I.S. 30S PG
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) CIPROFLOXACIN TABLETS USP 500MG I.S. 30S PG
SPECIAL FEATURES: (FEAT) STORE BELOW 30 DEGREES C (86 DEGREES F);ARMY OWNED PRODUCT; THIS NSN REPRESENTS A PACKAGE SIZE PREPARED BY REPACKING BULK MATERIEL. THE NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE REPACKAGED DOSAGE FORM. THE NSN IS NOT PROCURABE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, USP, 500 MG I.S. 30'S PACKAGE; THE LABEL FOR THIS NSN CONTAINS DIRECTIONS TO TAKE ONE DOSE EVERY 12 HOURS TO REDUCE THE CHANCE OF INFECTION AFTER EXPOSURE TO BIOLOGICAL AGENTS
ADMINISTRATION: (CSGS) ORAL
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 30.000 TABLETS
PROTECTIVE STORAGE FEATURE: (AJCN) EXPIRATION DATED AND SUBJECT TO DAMAGE BY FREEZING
FEATURES PROVIDED: (CBBL) INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: (CQCT) STRIP
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 500.000 KILOGRAMS PER CUBIC DECIMETER CIPROFLOXACIN HYDROCHLORIDE CUBIC CENTIMETERS
SPECIAL FEATURES: (FEAT) ISTORE BELOW 30 DEGREES C (86 DEGREES F);ARMY OWNED PRODUCT; THIS NSN REPRESENTS A PACKAGE SIZE PREPARED BY REPACKING BULK MATERIEL. THE NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE REPACKAGED DOSAGE FORM. THE NSN IS NOT PROCURABE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, USP, 500 MG I.S. 30'S PACKAGE; THE LABEL FOR THIS NSN CONTAINS DIRECTIONS TO TAKE ONE DOSE EVERY 12 HOURS TO REDUCE THE CHANCE OF INFECTION AFTER EXPOSURE TO BIOLOGICAL AGENTS
UNIT PACKAGE TYPE: (PKTY) PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 500.000 MILLIGRAMS CIPROFLOXACIN HYDROCHLORIDE ACTIVE INGREDIENT